Chan Henry Lik-Yuen, Tsang Steven Woon-Choi, Wong May-Ling, Tse Chi-Hang, Leung Nancy Wai-Yee, Chan Francis Ka-Leung, Sung Joseph Jao-Yiu
Am J Gastroenterol. 2002 Oct;97(10):2629-33. doi: 10.1111/j.1572-0241.2002.06065.x.
We aimed to investigate the association of viral genotype and the development of icteric flare-up (IF) in chronic hepatitis B virus (HBV) infection.
Twenty-one consecutive patients suffering from IF of chronic HBV infection, defined as elevation of ALT over five times the upper limit of normal, together with either bilirubin > 50 IU/L or elevated bilirubin plus PT > 3 s prolonged, were studied. Patients from three stages of HBV-related chronic liver disease were studied as controls: 1) asymptomatic carriers (31 patients), defined as persistent normal ALT for at least 2 yr; 2) active early cirrhosis (49 patients), defined as Child's A liver cirrhosis plus HBV DNA > 106 Eq/ml; and 3) decompensated cirrhosis (31 patients), defined as Child's B or C liver cirrhosis with complications. Restriction fragment length polymorphism was used for genotyping.
Only genotype B and C HBV were identified in our studied cohort. Ninety-one percent of patients suffering from IF were infected by genotype B HBV (p < 0.001 vs asymptomatic carriers, early cirrhosis patients, and decompensated cirrhosis patients). On the contrary, genotype C HBV was the predominant strain at different stages of chronic liver disease; no statistical difference was found on the relative prevalence of genotype B/C HBV among asymptomatic carriers, early cirrhosis patients, and decompensated cirrhosis patients.
Genotype B HBV is associated with IF among chronic HBV-infected patients in Hong Kong, whereas genotype C HBV is more prevalent at all stages of chronic liver disease. Our findings suggested that the two different HBV genotypes might have different pathogenic mechanisms of liver damage.
我们旨在研究慢性乙型肝炎病毒(HBV)感染中病毒基因型与黄疸发作(IF)的发生之间的关联。
对21例连续的慢性HBV感染且发生IF的患者进行研究,IF定义为谷丙转氨酶(ALT)升高超过正常上限的5倍,同时伴有胆红素>50 IU/L或胆红素升高加凝血酶原时间(PT)延长>3秒。研究了来自HBV相关慢性肝病三个阶段的患者作为对照:1)无症状携带者(31例),定义为ALT持续正常至少2年;2)早期活动性肝硬化(49例),定义为Child's A级肝硬化加HBV DNA>106 Eq/ml;3)失代偿期肝硬化(31例),定义为伴有并发症的Child's B级或C级肝硬化。采用限制性片段长度多态性进行基因分型。
在我们的研究队列中仅鉴定出B型和C型HBV。91%发生IF的患者感染了B型HBV(与无症状携带者、早期肝硬化患者和失代偿期肝硬化患者相比,p<0.001)。相反,C型HBV是慢性肝病不同阶段的主要毒株;在无症状携带者、早期肝硬化患者和失代偿期肝硬化患者中,B/C型HBV的相对流行率未发现统计学差异。
在香港,B型HBV与慢性HBV感染患者的IF相关,而C型HBV在慢性肝病的所有阶段更为普遍。我们的研究结果表明,两种不同的HBV基因型可能具有不同的肝损伤致病机制。